Molecular pathogenesis of thyroid cancer.
A number of molecular abnormalities have been described in association with the progression from normal thyroid tissue to benign adenomas to well-differentiated and finally anaplastic epithelial thyroid cancer. These include upregulation of proliferative factors, such as growth hormones and oncogenes, downregulation of apoptotic and cell-cycle inhibitory factors, such as tumor suppressors, disruption of normal cell-to-cell interactions, and cellular immortalization. The progression model for thyroid carcinoma has not been proven, but evidence suggests that an evolutionary molecular process is involved, especially in the development of follicular thyroid cancers for which there are distinct intermediate phenotypes. We present a comprehensive evaluation of factors involved in thyroid tumorigenesis and attempt to describe preliminary attributes of a progression model. The organization of this model should also provide a template for the incorporation of new information as it is derived from large-scale genomic studies.
Segev
Dorry L
DL
Department of Surgery, Johns Hopkins Medical Institutions, 600 N. Wolfe Street, Baltimore, MD 21287, USA.
Umbricht
Christopher
C
Zeiger
Martha A
MA
D017209:Apoptosis / Q000502:physiology; D018450:Disease Progression; D006133:Growth Substances / Q000378:metabolism; D019382:Human Growth Hormone / Q000378:metabolism; D006801:Humans; D009857:Oncogenes / Q000502:physiology; D012307:Risk Factors; D013964:Thyroid Neoplasms / Q000503:physiopathology*
D006133:Growth Substances; D019382:Human Growth Hormone